Drug Research

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets. The LPS in vivo model supports...

An Innovate UK-backed biotech company has achieved a pioneering biocomputer breakthrough which is accelerating the development and manufacture of cheaper drugs and vaccines. BiologIC Technologies, inventor of the world’s first biocomputer, has developed 3D printed ‘lab-on-a-chip’ platforms - miniaturised devices...

The Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is expected to see significant growth. Factors driving this include rising pharmaceutical demand, increased focus on research and development, and the outsourcing of drug development and manufacturing. The...

According to insights, the market for contract development and manufacturing organizations (CDMOs) specializing in small molecule innovation is estimated to reach a value of $48.09 billion in 2023 and $89.43 billion in 2033. The sales in this market are...

Aseptic fill/finish experts Flexicon Liquid Filling, part of Watson-Marlow Fluid Technology Solutions (WMFTS), and barrier technology specialists Franz Ziel GmbH, announces Cellefill™, a turnkey, vial fill/finish system with an integrated barrier solution. Enhancing good manufacturing practice (GMP), customer compliance and...

Recent insights suggest that the pharmaceutical sterility testing market is projected to grow from $0.636 billion in 2023 to $1.0223 billion by 2032. Factors such as the increasing emphasis on quality and sterility, government investments, and the introduction of...

In Hong Kong, lung cancer continues to be the most prevalent form of cancer. Despite its status as a prominent global cause of cancer-related deaths, there is still a need for a significant breakthrough in its treatment. The Faculty...